Sunday, 28 September, 2025г.
russian english deutsch french spanish portuguese czech greek georgian chinese japanese korean indonesian turkish thai uzbek

пример: покупка автомобиля в Запорожье

 

Pembrolizumab shows promising activity against head and neck cancer

Pembrolizumab shows promising activity against head and neck cancerУ вашего броузера проблема в совместимости с HTML5
Visit http://www.ecancer.org for more Dr Tanguy Seiwert (University of Chicago, Chicago, USA) talks to ecancertv at ASCO 2015 about a 132-patient study indicates that pembrolizumab immunotherapy is effective for patients with recurrent or metastatic head and neck cancer (HNC).
Опубликовано: 30-06-2015
Теги: Head And Neck Cancer (Disease Or Medical Condition) pembrolizumab

Похожие видео
ESMO Expert Video Report on Immunotherapy for Head and Neck Cancer

ESMO Expert Video Report on Immunotherapy for Head and Neck Cancer04:28

Phase III trial shows pembrolizumab preferable to ipilimumab in advanced melanoma

Phase III trial shows pembrolizumab preferable to ipilimumab in advanced melanoma05:37

NSCLC Immunotherapy: A New Hope

NSCLC Immunotherapy: A New Hope11:53

Daniel Catenacci, MD, elaborates on the outcomes of the JAVELIN 100 study presented at ASCO GI 2020

Daniel Catenacci, MD, elaborates on the outcomes of the JAVELIN 100 study presented at ASCO GI 202002:43

Мой аккаунт

Вход / Log In